V

VistaGen Therapeutics
D

VTGN

2.40000
USD
-0.03
(-1.23%)
مغلق
حجم التداول
325
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
69,269,004
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
A
APVO
-0.03210
(-10.63%)
0.26990 USD
C
CLDX
-0.010
(-0.05%)
20.375 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
M
MNKD
-0.10500
(-2.49%)
4.12000 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
S
SUPN
0.070
(0.22%)
32.100 USD
T
TBPH
-0.18500
(-1.95%)
9.31000 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.